Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Exogenous progesterone as ovulation trigger – pilot study
2025-523850-15-00Phase 4Authorised
- Sponsor
- IVI
- Start
- May 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of progesterone in infertility, sponsored by IVI. Primary endpoint: Number of mature oocytes (MII) following progesterone-induced oocyte maturation. Planned start May 2026; status: authorised.
02
Drugs
progesterone
03
Conditions
infertility
Beyond the preview
Go deeper on 2025-523850-15-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2025-523850-15-00.